Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

Palliative Care May Reduce Invasive Intervention Use in Early-Onset CRC

February 5th 2025, 2:00pm

Article

Palliative care for young adults with colorectal cancer reduced invasive procedures, costs and increased DNR orders.

Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

February 3rd 2025, 8:00pm

Article

Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.

Breaking Down Cancer Therapies Approved by the FDA in January 2025

February 3rd 2025, 4:00pm

Article

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

Opdivo Plus Yervoy Improves Outcomes in Metastatic Colorectal Cancer Subset

January 29th 2025, 8:00pm

Article

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic colorectal cancer.

Study Shows Poor Outcomes in BRAF V600E-Mutant Metastatic CRC

January 26th 2025, 7:00pm

Article

Synchronous metastases did not affect survival in resected BRAF V600E-mutated metastatic colorectal cancer.

The BREAKWATER Trial Explores Braftovi, Erbitux and Chemo in BRAF V600E+ mCRC

January 26th 2025, 3:00pm

Video

Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ metastatic colorectal cancer.

Aspirin May Reduce Recurrence in PI3K-mutated Colorectal Cancer

January 25th 2025, 3:02pm

Article

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance of upfront genomic testing.

Second Cancer Risk Heightened After Appendiceal Adenocarcinoma Diagnosis

January 24th 2025, 5:18pm

Article

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

Understanding the Concept of MRD for Patients With Cancer

January 22nd 2025, 4:00pm

Article

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients.

The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors

January 20th 2025, 2:00pm

Article

Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.